Drug&#39;s withdrawal puts heat on FDA Agency too reliant on drug ...
33483
Suspicions that the arthritis drug Vioxx could cause serious cardiovascular damage arose as early as 1999, the year Vioxx was approved by the Food and Drug Administration as a next-generation remedy that might be safer than older drugs like ibuprofen.
545492
Is the US Food &amp; Drug Administration failing? That was the testimony of one senior FDA official last week concerning Merck&#39;s withdrawal of the Vioxx anti-pain drug.
69180
FDA commissioner Andrew von Eschenbach took a tongue-lashing from members of Congress over the way his agency handled Avandia, the diabetes drug from GlaxoSmithKline that has come under scrutiny for alleged heart attack risks.
2756
NEW YORK - The pharmaceutical industry has endured a disastrous 2004, and the aftermath will linger into the new year. Regulators at the Food and Drug Administration were expected to take a more cautious approach
265006
U.S. lawmakers and health officials  are moving to give more independence to an office that reviews  drug safety, but some experts say ensuring medicines are  studied after they hit the market is more important than the  bureaucratic pecking order.
41829
The Food and Drug Administration of the US found itself in the midst of a rather unpleasant controversy. Recently the chief of Cleveland Clinic Foundationâs department of cardiovascular medicine blamed this
404541
The report is likely to intensify a debate about the safety of the nationÂs drug supply and the adequacy of government oversight.
314104
The U.S. Food and Drug Administration said on Tuesday it was creating an independent drug safety board after the agency's monitoring of drugs already in the marketplace was criticized amid the withdrawal of arthritis drug Vioxx.
695199
Less than three months after Merck withdrew its pain-killer Vioxx from the US after concerns about side-effects, questions over Pfizer&#39;s competitor products are provoking
374846
It was just a month ago that I wrote about the frightening lack of agreement among FDA officials regarding drugs that were already on the market.
185146
Two revelations last week of Food and Drug Administration foot-dragging place in doubt whether the agency can effectively serve and protect consumers.
326837
Last weekâs dramatic withdrawal of the COX-2 inhibitor rofecoxib (Vioxx) is discussed in this weekâs lead editorial in THE LANCET, which comments that more vigilant drug licensing is vital to prevent the endangering of patientsâ health.
238158
Health care advocates, providers and FDA officials over the weekend &#39;sparred&#39; over alleged problems with the FDA prescription drug safety review process and the safety of five medications currently on the market, after an FDA safety reviewer on Thursday
212028
Drug companies rushing to fill the vacuum left by Merck &amp; Co.&#39;s withdrawal of its best-selling arthritis drug Vioxx are flooding the airwaves with competing
744549
A pair of Food and Drug Administration advisory panels called yesterday for new warnings for the widely used diabetes drug Avandia because of evidence that it significantly raises the risk of heart attack, but they stopped short of recommending that the drug be pulled from the market, as some FDA...
49837
The abrupt withdrawal last week of the best-selling painkiller Vioxx is an event rich in ironies and lessons that may ultimately lead to a rethinking of the way drug safety is evaluated in the United States.
235661
WASHINGTON -- A Food and Drug Administration official is defending the agency&#39;s action with regards to Vioxx. The drug was taken off the market Sept.